Pages that link to "Q70274643"

The following pages link to The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells (Q70274643):

Displaying 28 items.

• Alterations in phosphorus, calcium and PTHrP contribute to defects in dental and dental alveolar bone formation in calcium-sensing receptor-deficient mice (Q33710898) (← links)
• The Abnormal Phenotypes of Cartilage and Bone in Calcium-Sensing Receptor Deficient Mice Are Dependent on the Actions of Calcium, Phosphorus, and PTH (Q34037713) (← links)
• Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure (Q34543837) (← links)
• Desensitization to parathyroid hormone in renal cells from aged rats is associated with alterations in G-protein activity (Q34564733) (← links)
• PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels (Q35417067) (← links)
• Vitamin D metabolism: new concepts and clinical implications (Q35754263) (← links)
• Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report (Q35938506) (← links)
• Pathogenesis of parathyroid dysfunction in end-stage kidney disease (Q35953382) (← links)
• Cellular physiology and pathophysiology of the parathyroid glands (Q36901367) (← links)
• Vitamin D Receptors And Parathyroid Glands (Q37860024) (← links)
• Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure (Q39246280) (← links)
• Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. (Q40305016) (← links)
• Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium (Q40379315) (← links)
• The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion (Q40511401) (← links)
• Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism (Q42558853) (← links)
• Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy (Q44542743) (← links)
• Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. (Q54301337) (← links)
• Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease (Q57226001) (← links)
• Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol (Q67595254) (← links)
• Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3 (Q68231180) (← links)
• Effect of 1,25-dihydroxyvitamin D3 on cytosolic calcium in dispersed parathyroid cells (Q68418922) (← links)
• Effects of high concentrations of glucose on PTH secretion in parathyroid cells (Q68521891) (← links)
• 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs (Q69341558) (← links)
• 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells (Q70416231) (← links)
• Coordinate regulation of PTH/PTHrP receptors by PTH and calcitriol in UMR 106-01 osteoblast-like cells (Q71532963) (← links)
• In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism (Q71834051) (← links)
• The contribution of acidosis to renal osteodystrophy (Q71979490) (← links)
• Pathogenesis of secondary hyperparathyroidism (Q72780094) (← links)